prokinetic


Also found in: Dictionary, Thesaurus, Legal, Wikipedia.

prokinetic

 [pro″kĭ-net´ik]
stimulating movement or motility, such as a drug that promotes gastrointestinal motility.

prokinetic

/pro·ki·net·ic/ (pro″kĭ-net´ik) stimulating movement or motility.

prokinetic

[pro′kinet′ik]
stimulating movement or motility, such as a drug that promotes GI motility.

Prokinetic

A drug that works to speed up the emptying of the stomach and the motility of the intestines.
Mentioned in: Indigestion
References in periodicals archive ?
Drug therapy can include antiemetics, prokinetic agents, and proton pump inhibitors to limit acid, which slows gastric emptying.
Cisapride was developed as a "targeted" prokinetic agent with a unique mechanism of action.
Ulimorelin is an intravenous ghrelin agonist with potent prokinetic properties in clinical development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
The prokinetic agents include metoclopramide and bethanechol, and the newer compounds cisapride and domperidone.
Overall, 42 of these patients resolved their cough with protonpump inhibitors alone or in combination with a prokinetic agent; they required 26 weeks to respond.
2] blockers, and prokinetic agents, but their effects are much swifter.
0 million nonrefundable upfront license fee received from P&G as a result of P&G's termination of their collaboration agreement with ARYx covering the company's prokinetic agent, ATI-7505.
Although tegaserod is approved for treating IBS with constipation, its prokinetic effects have led to on-going studies of the drug in diabetic gastroparesis, chronic constipation, and other dysmotility syndromes.
First-line treatment for gastroparesis is a prokinetic agent or erythromycin, Dr.
In one recent study of 12 infants, treatment with prokinetic agents and [H.
ARYx currently has four products in clinical development: an oral anti-arrhythmic agent for the treatment of atrial fibrillation, budiodarone (ATI-2042); a prokinetic agent for the treatment of various gastrointestinal disorders, ATI-7505; an oral anticoagulant agent for patients at risk for the formation of dangerous blood clots, tecarfarin (ATI-5923); and, an agent for the treatment of schizophrenia and other psychiatric disorders, ATI-9242.
Patients with severe gastroparesis are usually treated with nutritional support, antiemetics, and prokinetic drugs.